Comparing two medicines for ovulation in PCOS
Treatments studied
Part of Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study tests if adding cabergoline to letrozole works better than letrozole alone to help women with PCOS ovulate. It may help participants who have not had success with standard treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Diagnosed with PCOS using standard criteria
- Between 18 and 35 years old
- Having trouble getting pregnant (primary or secondary infertility)
- Your doctor has recommended ovulation induction
- Not taking certain other medications that could interfere
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if liraglutide, a weight-loss medication, can help obese women with PCOS who have a frozen embryo achieve pregnancy. It aims to improve fertility outcomes by aiding weight loss before embryo transfer.
This trial tests a longer course of letrozole to help women with PCOS ovulate and get pregnant. The goal is to see if extended therapy works better than the standard treatment.
This trial tests whether letrozole, a medicine that helps with ovulation, works for women with PCOS. It looks at lab results and ultrasound findings to see how well the treatment works.
This trial tests whether adding a low-dose thyroid hormone (levothyroxine) to the standard fertility treatment letrozole improves pregnancy rates in women with both PCOS and mild hypothyroidism. It may help if you have trouble getting pregnant and have these two conditions.
This trial tests if combining two fertility medications (letrozole and clomiphene citrate) works better than using letrozole alone to help women with ovulation problems release an egg. The goal is to find a more effective treatment for women trying to conceive.
This study tests whether a medicine called cabergoline can lower the chance of ovarian hyperstimulation syndrome (OHSS) in women undergoing IVF who are at high risk. It compares cabergoline with a standard technique called 'coasting' (stopping fertility drugs for a few days).
Hear when a new PCOS trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.